References

1. Gutiérrez-Fernández M, Rodríguez-Frutos B, Fuentes B, Vallejo-Cremades MT, Alvarez-Grech J, et al. (2012) CDP-choline treatment induces brain plasticity markers expression in experimental animal stroke. Neurochem Int 60: 310-317 [CrossRef] [Google Scholar] [PubMed]
2. Secades JJ (2011) Citicoline: pharmacological and clinical review, 2010 update. Rev Neurol 52 Suppl 2: S1-1S62 [Google Scholar] [PubMed]
3. Goas JY, Bastard J, Missoum A (1980) Bilan a 90 jours du traitement des accidents vasculaires cerebraux par la CDP-choline: A propos d'un essai en double insu. Symposium International: Souffrance cerebrale et precurseurs des phospholipides, Paris
4. Boudouresques P, Alonzo B, Michel B (1980) Conduite therapeutique devant un accident vasculaire cerebral: Place de la CDP-choline. Symposium International: Souffrance cerebrale et precurseurs des phospholipides, Paris
5. Corso EA, Arena M, Ventimiglia A, Bizzarro G, Campo G, et al. (1982) [CDP choline in cerebral vasculopathy: clinical evaluation and instrumental semeiology]. Clin Ter 102: 379-386 [Google Scholar] [PubMed]
6. Tazaki Y, Sakai F, Otomo E, Kutsuzawa T, Kameyama M, et al. (1988) Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study. Stroke 19: 211-216 [CrossRef] [Google Scholar] [PubMed]
7. Clark WM, Warach SJ, Pettigrew LC, Gammans RE, Sabounjian LA (1997) A randomized dose-response trial of citicoline in acute ischemic stroke patients. Citicoline Stroke Study Group. Neurology 49: 671-678 [CrossRef] [Google Scholar] [PubMed]
8. Clark WM, Williams BJ, Selzer KA, Zweifler RM, Sabounjian LA, et al. (1999) A randomized efficacy trial of citicoline in patients with acute ischemic stroke. Stroke 30: 2592-2597 [CrossRef] [Google Scholar] [PubMed]
9. Warach S, Pettigrew LC, Dashe JF, Pullicino P, Lefkowitz DM, et al. (2000) Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators. Ann Neurol 48: 713-722 [CrossRef] [Google Scholar] [PubMed]
10. Clark WM, Wechsler LR, Sabounjian LA, Schwiderski UE; Citicoline Stroke Study Group (2001) A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients. Neurology 57: 1595-1602 [CrossRef] [Google Scholar] [PubMed]
11. Dávalos A, Castillo J, Alvarez-Sabín J, Secades JJ, Mercadal J, et al. (2002) Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials. Stroke 33: 2850-2857 [CrossRef] [Google Scholar] [PubMed]
12. Saver JL (2008) Citicoline: update on a promising and widely available agent for neuroprotection and neurorepair. Rev Neurol Dis 5: 167-177 [Google Scholar] [PubMed]
13. Casado A, Secades JJ, Ibarz R, Herdman M, Brosa M (2008) Costeffectiveness of citicoline versus conventional treatment in acute ischemic stroke. Expert Rev Pharmacoecon Outcomes Res 8: 151-157 [CrossRef] [Google Scholar] [PubMed]
14. http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?ID=22008100436 [View]
15. Dávalos A, Alvarez-Sabín J, Castillo J, Díez-Tejedor E, Ferro J, et al. (2012) Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial). Lancet 380: 349-357 [CrossRef] [Google Scholar] [PubMed]
16. Hamada J, Mizuno T, Kai Y, Morioka M, Ushio Y (2000) Microcatheter intrathecal urokinase infusion into cisterna magna for prevention of cerebral vasospasm: preliminary report. Stroke 31: 2141-2148 [CrossRef] [Google Scholar] [PubMed]
17. Secades JJ, Delgadillo J, Oudovenko N (2013) Role of citicoline on the treatment of ischemic stroke: a formal and cumulative meta-analysis. 7th World Congress on Controversies in Neurology. Istanbul, Turkey
18. Fioravanti M, Yanagi M (2005) Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Cochrane Database Syst Rev 4: CD000269 [CrossRef] [Google Scholar] [PubMed]
19. Alvarez-Sabín J, Ortega G, Jacas C, Santamarina E, Maisterra O, et al. (2013) Long-term treatment with citicoline may improve poststroke vascular cognitive impairment. Cerebrovasc Dis 35: 146-154 [CrossRef] [Google Scholar] [PubMed]
20. Cotroneo AM, Castagna A, Putignano S, Lacava R, Fantò F, et al. (2013) Effectiveness and safety of citicoline in mild vascular cognitive impairment: the IDEALE study. Clin Interv Aging 8: 131-137 [CrossRef] [Google Scholar] [PubMed]
21. Secades JJ (2012) Probably role of citicoline in stroke rehabilitation: review of the literature. Rev Neurol 54: 173-179. [Google Scholar] [PubMed]
22. Secades JJ (2014) Citicoline for Treatment of Head Trauma. Systematic Review and Meta-analysis of Clinical Controlled Trials. J Trauma Treat 4:1
23. León-Carrión J, Dominguez-Roldán JM, Murillo-Cabezas F, del Rosario Dominguez-Morales M, Muñoz-Sanchez MA (2000) The role of citicholine in neuropsychological training after traumatic brain injury. NeuroRehabilitation 14: 33-40 [Google Scholar] [PubMed]